DK2359864T3 - Målrettende vektor-phospholipid-konjugater - Google Patents

Målrettende vektor-phospholipid-konjugater

Info

Publication number
DK2359864T3
DK2359864T3 DK10190163.5T DK10190163T DK2359864T3 DK 2359864 T3 DK2359864 T3 DK 2359864T3 DK 10190163 T DK10190163 T DK 10190163T DK 2359864 T3 DK2359864 T3 DK 2359864T3
Authority
DK
Denmark
Prior art keywords
targeting vector
phospholipid conjugates
phospholipid
conjugates
targeting
Prior art date
Application number
DK10190163.5T
Other languages
English (en)
Inventor
Philippe Bussat
Samir Cherkaoui
Hong Fan (Helen)
Bernard Lamy
Palaniappa Nanjappan
Radhakrishna K Pillai
Sibylle Pochon
Bo Song
Rolf E Swenson
Original Assignee
Bracco Suisse Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Suisse Sa filed Critical Bracco Suisse Sa
Application granted granted Critical
Publication of DK2359864T3 publication Critical patent/DK2359864T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544Phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/14Peptides, e.g. proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/22Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography
DK10190163.5T 2005-12-09 2006-12-08 Målrettende vektor-phospholipid-konjugater DK2359864T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74924005P 2005-12-09 2005-12-09
US83334206P 2006-07-25 2006-07-25
EP06840164.5A EP1966388B1 (en) 2005-12-09 2006-12-08 Targeting vector-phospholipid conjugates

Publications (1)

Publication Number Publication Date
DK2359864T3 true DK2359864T3 (da) 2019-07-08

Family

ID=38123651

Family Applications (2)

Application Number Title Priority Date Filing Date
DK06840164.5T DK1966388T3 (da) 2005-12-09 2006-12-08 Tilsigte vektor-fosfolipidkonjugater
DK10190163.5T DK2359864T3 (da) 2005-12-09 2006-12-08 Målrettende vektor-phospholipid-konjugater

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK06840164.5T DK1966388T3 (da) 2005-12-09 2006-12-08 Tilsigte vektor-fosfolipidkonjugater

Country Status (13)

Country Link
EP (2) EP2359864B1 (da)
JP (2) JP5242408B2 (da)
KR (3) KR20140083052A (da)
CN (2) CN103204911B (da)
AU (1) AU2006321613B2 (da)
BR (1) BRPI0619522B8 (da)
CA (3) CA2631716C (da)
DK (2) DK1966388T3 (da)
ES (1) ES2428964T3 (da)
IL (1) IL191850A (da)
MX (1) MX2008007321A (da)
RU (1) RU2433137C2 (da)
WO (1) WO2007067979A2 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1587944A4 (en) 2002-03-01 2007-03-21 Dyax Corp KDR AND VEGF / KDR BINDING PEPTIDES AND THEIR USE FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US7985402B2 (en) * 2002-03-01 2011-07-26 Bracco Suisse Sa Targeting vector-phospholipid conjugates
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
SI2949658T1 (sl) * 2003-03-03 2018-10-30 Dyax Corp. Peptidi, ki specifično vežejo HGF receptor (cMet) in njihove uporabe
CN101094867B (zh) 2004-10-19 2011-08-24 隆萨股份公司 用于固相肽合成的方法
CA2631716C (en) * 2005-12-09 2013-11-26 Bracco International B.V. Targeting vector-phospholipid conjugates
US20110160431A1 (en) * 2009-04-06 2011-06-30 Novetide, Ltd. Production of peptides containing poly-gly sequences using fmoc chemistry
CN101637613B (zh) * 2009-08-19 2011-09-14 王维 一种脂质靶向超声造影剂及其制备方法
EP2603242B1 (en) 2010-08-09 2018-03-14 Bracco Suisse SA Targeted gas-filled microvesicles
CN102286076B (zh) * 2011-06-23 2014-03-12 成都圣诺科技发展有限公司 比伐卢定的制备方法
WO2014096165A2 (en) * 2012-12-21 2014-06-26 Bracco Suisse Sa Gas-filled microvesicles
HUE043680T2 (hu) * 2014-12-18 2019-09-30 Bracco Suisse Sa Célbajuttató gázzal töltött mikrorészecske készítmény
US20190046667A1 (en) * 2016-02-01 2019-02-14 Trust Biosonics Inc. Lipid microbubbles and process of making thereof
WO2018140425A1 (en) * 2017-01-24 2018-08-02 Nuvox Pharma Llc Iso-osmotic and near iso-osmotic oxygen therapeutic formulations and methods thereof
EP3360884A1 (en) * 2017-02-10 2018-08-15 Neuronax Improved process for the preparation of a dodecapeptide
KR20210106418A (ko) 2018-12-18 2021-08-30 브라코 스위스 에스.에이. 다이머 펩타이드-인지질 콘쥬게이트를 위한 최적화 과정
US11717570B2 (en) 2019-05-15 2023-08-08 Bracco Suisse Sa Gas-filled microvesicles
US20200360289A1 (en) 2019-05-15 2020-11-19 Bracco Suisse Sa Freeze-dried product and gas-filled microvesicles suspension
WO2023103963A1 (en) * 2021-12-06 2023-06-15 Westlake Therapeutics (Shanghai) Co., Limited Modified cells and uses thereof for delivering agents

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5445813A (en) 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
IN172208B (da) 1990-04-02 1993-05-01 Sint Sa
US5578292A (en) 1991-11-20 1996-11-26 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US5556610A (en) 1992-01-24 1996-09-17 Bracco Research S.A. Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method
IL104084A (en) 1992-01-24 1996-09-12 Bracco Int Bv Sustainable aqueous suspensions of pressure-resistant and gas-filled blisters, their preparation, and contrast agents containing them
US5338725A (en) * 1992-06-30 1994-08-16 The Research Foundation Of The State University Of New York Anti-aggregatory agents for platelets
KR100295173B1 (ko) 1993-12-15 2001-09-17 엔. 토모브 초음파콘트라스트매질로서유용한가스혼합물
IL116328A (en) 1994-12-16 1999-09-22 Bracco Research Sa Frozen suspension of gas microbubbles in frozen aqueous carrier for use as contrast agent in ultrasonic imaging
EP1444991A1 (en) * 1995-06-07 2004-08-11 Imarx Pharmaceutical Corp. Novel targeted compositions for diagnostic and therapeutic use
EP0881915B1 (en) 1996-02-19 2003-04-23 Amersham Health AS Improvements in or relating to contrast agents
WO1998005364A2 (en) 1996-08-02 1998-02-12 Marsden, John, Christopher Improvements in or relating to contrast agents
US6071532A (en) * 1996-10-15 2000-06-06 Emory University Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof
EE03749B1 (et) 1996-10-21 2002-06-17 Nycomed Imaging As Kombineeritud preparaat samaaegseks, eraldi või järjestikuseks kasutamiseks kontrastainena ultrahelikujutamisel
WO1998018501A2 (en) 1996-10-28 1998-05-07 Marsden, John, Christopher Improvements in or relating to diagnostic/therapeutic agents
EP0991427A2 (en) 1996-10-28 2000-04-12 Marsden, John Christopher Improvements in or relating to diagnostic/therapeutic agents
WO1998018498A2 (en) 1996-10-28 1998-05-07 Marsden, John, Christopher Improvements in or relating to diagnostic/therapeutic agents
ES2257771T3 (es) 1996-10-28 2006-08-01 Amersham Health As Agentes de contraste.
EP0946202B1 (en) 1996-10-28 2003-09-10 Amersham Health AS Contrast agents
US6245318B1 (en) 1997-05-27 2001-06-12 Mallinckrodt Inc. Selectively binding ultrasound contrast agents
GB9809084D0 (en) * 1998-04-28 1998-06-24 Nycomed Imaging As Improvements in or relating to diagnostic/therapeutic agents
EP2279757A3 (en) * 2000-06-02 2011-08-03 Bracco Suisse SA Compounds for targeting endothelial cells
US7666979B2 (en) * 2002-03-01 2010-02-23 Bracco International B.V. Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same
CA2477935C (en) * 2002-03-01 2015-01-06 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US20050250700A1 (en) * 2002-03-01 2005-11-10 Sato Aaron K KDR and VEGF/KDR binding peptides
EP1587944A4 (en) * 2002-03-01 2007-03-21 Dyax Corp KDR AND VEGF / KDR BINDING PEPTIDES AND THEIR USE FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
JP2006514915A (ja) * 2002-03-01 2006-05-18 ダイアックス、コープ Kdrおよびvegf/kdr結合ペプチドならびに診断および治療におけるその使用
KR101076053B1 (ko) 2003-02-04 2011-10-21 브라코 인터내셔날 비.브이. 초음파 조영제 및 그것의 제조방법
FI20031528A0 (fi) * 2003-10-17 2003-10-17 Ctt Cancer Targeting Tech Oy Terapeuttinen liposomikoostumus ja menetelmä sen valmistamiseksi
CA2631716C (en) * 2005-12-09 2013-11-26 Bracco International B.V. Targeting vector-phospholipid conjugates

Also Published As

Publication number Publication date
CA2631716A1 (en) 2007-06-14
JP2009518448A (ja) 2009-05-07
EP2359864A2 (en) 2011-08-24
EP1966388B1 (en) 2013-08-07
IL191850A (en) 2014-06-30
EP1966388A2 (en) 2008-09-10
CN101374955A (zh) 2009-02-25
RU2008127836A (ru) 2010-01-20
BRPI0619522B8 (pt) 2021-07-27
CA2947346A1 (en) 2007-06-14
ES2428964T3 (es) 2013-11-12
KR20090009187A (ko) 2009-01-22
KR20140083052A (ko) 2014-07-03
JP2013136608A (ja) 2013-07-11
JP5242408B2 (ja) 2013-07-24
AU2006321613B2 (en) 2012-01-12
JP5735993B2 (ja) 2015-06-17
MX2008007321A (es) 2008-09-30
CA2631716C (en) 2013-11-26
CN101374955B (zh) 2013-03-27
WO2007067979A3 (en) 2008-07-31
CA2947346C (en) 2018-07-24
KR101323849B1 (ko) 2013-11-07
KR20130099251A (ko) 2013-09-05
EP1966388A4 (en) 2009-11-25
EP2359864A3 (en) 2012-08-01
CN103204911B (zh) 2015-04-01
DK1966388T3 (da) 2013-10-28
EP2359864B1 (en) 2019-04-17
BRPI0619522B1 (pt) 2020-11-24
CA2826960A1 (en) 2007-06-14
BRPI0619522A2 (pt) 2011-10-04
WO2007067979A2 (en) 2007-06-14
RU2433137C2 (ru) 2011-11-10
KR101658439B1 (ko) 2016-09-21
IL191850A0 (en) 2008-12-29
CN103204911A (zh) 2013-07-17
AU2006321613A1 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
DK2359864T3 (da) Målrettende vektor-phospholipid-konjugater
DK1912671T3 (da) Beta-glucuronid-linker-lægemiddelkonjugater
DK2444807T3 (da) Mono- og dinitropyrazolhaptenkonjugater
ATE443753T1 (de) Nuancierungsmittel
DE602006002527D1 (de) Versiegelungsvorrichtung
DE112006001565A5 (de) Nanopartikel-Wirkstoff-Konjugate
BRPI0923047A2 (pt) "conjugados de proteínas-oligossacarídeos".
DE602007009378D1 (de) Vr1-benzimidazolmodulatoren
EP1948600A4 (en) TARGET CONJUGATES ON THE LIVER
DE602006006395D1 (de) Versiegelungsgerät
DK1960429T3 (da) Immunglobuliner rettet mod NOGO
DE502007000476D1 (de) Verbundlenkerachse
ITMI20060108A1 (it) Dispsotivo avvolgitore
DE502006006589D1 (de) Teils
SE0501828L (sv) Rörelsetransformerande arrangemang
DE602006007836D1 (de) Kontrastmittel
AT505229A3 (de) Potenzhilfe ''penisschlauch''
FI20065208A0 (fi) Peptidikonjugaatteja
DE602005020522D1 (de) Dreidimensionaler lochfilm
DE502007000078D1 (de) Verbundlenkerachse
DE502006008206D1 (de) Steckverbinder
SI1966388T1 (sl) Konjugati iz ciljnega vektorja in fosfolipidov
SE0501759L (sv) Smutsavvisande formuleringar
AU2005903324A0 (en) Targeting vector
UA11461S (uk) Рекламний щит